Johnson & Johnson (NYSE:JNJ) had its "buy" rating reaffirmed by analysts at Guggenheim.
Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson and Sanofi [Yahoo! Finance]
Johnson & Johnson (JNJ): A Bull Case Theory [Yahoo! Finance]
Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note [Yahoo! Finance]
Intraocular Lens Market Competitor Analysis Report 2025: Recent Developments, Strategy, Sustainability Benchmarking, Product Launch, Key Persons and Revenue [Yahoo! Finance]